Altre lingue Forte Biosciences, Inc.

Azioni

FBRX

US34962G1094

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
0,745 ^USD	+2,41%		+7,94%	-9,33%

18/03	Forte Biosciences, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
05/01	Camac Partners fornisce informazioni agli azionisti	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update	18/03
Camac Partners Provides Information to Shareholders	05/01
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules	01/12
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update	13/11
Forte Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Tocagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Forte Biosciences Filed a Motion to Dismiss the Amended Complaint	28/10/23
Camac Fund Files an Amended Class Action and Derivative Complaint	20/10/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	26/09/23
Declaration of Voting Results by Forte Biosciences	20/09/23
Forte Biosciences, Inc. Announces Directorate Appointments	20/09/23
Institutional Shareholder Services and Glass Lewis Support Camac Partners	14/09/23
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting	14/09/23
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom	06/09/23
Camac Partners Shares Key Facts that Reinforce the Need for Urgent Change in Forte Biosciences?s Boardroom	06/09/23
Forte Biosciences Issues an Investor Presentation to Shareholders	01/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Forte Biosciences, Inc.

Azioni

FBRX

US34962G1094

Altre lingue

Filtri